Literature DB >> 17507479

Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.

Barry Rockx1, Timothy Sheahan, Eric Donaldson, Jack Harkema, Amy Sims, Mark Heise, Raymond Pickles, Mark Cameron, David Kelvin, Ralph Baric.   

Abstract

The severe acute respiratory syndrome (SARS) epidemic was characterized by high mortality rates in the elderly. The molecular mechanisms that govern enhanced susceptibility of elderly populations are not known, and robust animal models are needed that recapitulate the increased pathogenic phenotype noted with increasing age. Using synthetic biology and reverse genetics, we describe the construction of a panel of isogenic SARS coronavirus (SARS-CoV) strains bearing variant spike glycoproteins that are representative of zoonotic strains found in palm civets and raccoon dogs, as well as isolates spanning the early, middle, and late phases of the SARS-CoV epidemic. The recombinant viruses replicated efficiently in cell culture and demonstrated variable sensitivities to neutralization with antibodies. The human but not the zoonotic variants replicated efficiently in human airway epithelial cultures, supporting earlier hypotheses that zoonotic isolates are less pathogenic in humans but can evolve into highly pathogenic strains. All viruses replicated efficiently, but none produced clinical disease or death in young animals. In contrast, severe clinical disease, diffuse alveolar damage, hyaline membrane formation, alveolitis, and death were noted in 12-month-old mice inoculated with the palm civet HC/SZ/61/03 strain or early-human-phase GZ02 variants but not with related middle- and late-phase epidemic or raccoon dog strains. This panel of SARS-CoV recombinants bearing zoonotic and human epidemic spike glycoproteins will provide heterologous challenge models for testing vaccine efficacy against zoonotic reintroductions as well as provide the appropriate model system for elucidating the complex virus-host interactions that contribute to more-severe and fatal SARS-CoV disease and acute respiratory distress in the elderly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507479      PMCID: PMC1933338          DOI: 10.1128/JVI.00505-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human.

Authors:  Huai-Dong Song; Chang-Chun Tu; Guo-Wei Zhang; Sheng-Yue Wang; Kui Zheng; Lian-Cheng Lei; Qiu-Xia Chen; Yu-Wei Gao; Hui-Qiong Zhou; Hua Xiang; Hua-Jun Zheng; Shur-Wern Wang Chern; Feng Cheng; Chun-Ming Pan; Hua Xuan; Sai-Juan Chen; Hui-Ming Luo; Duan-Hua Zhou; Yu-Fei Liu; Jian-Feng He; Peng-Zhe Qin; Ling-Hui Li; Yu-Qi Ren; Wen-Jia Liang; Ye-Dong Yu; Larry Anderson; Ming Wang; Rui-Heng Xu; Xin-Wei Wu; Huan-Ying Zheng; Jin-Ding Chen; Guodong Liang; Yang Gao; Ming Liao; Ling Fang; Li-Yun Jiang; Hui Li; Fang Chen; Biao Di; Li-Juan He; Jin-Yan Lin; Suxiang Tong; Xiangang Kong; Lin Du; Pei Hao; Hua Tang; Andrea Bernini; Xiao-Jing Yu; Ottavia Spiga; Zong-Ming Guo; Hai-Yan Pan; Wei-Zhong He; Jean-Claude Manuguerra; Arnaud Fontanet; Antoine Danchin; Neri Niccolai; Yi-Xue Li; Chung-I Wu; Guo-Ping Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-04       Impact factor: 11.205

2.  Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters.

Authors:  Anjeanette Roberts; Leatrice Vogel; Jeannette Guarner; Norman Hayes; Brian Murphy; Sherif Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents.

Authors:  Choong-Tat Keng; Aihua Zhang; Shuo Shen; Kuo-Ming Lip; Burtram C Fielding; Timothy H P Tan; Chih-Fong Chou; Chay Boon Loh; Sifang Wang; Jianlin Fu; Xiaoming Yang; Seng Gee Lim; Wanjin Hong; Yee-Joo Tan
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates.

Authors:  Donglai Wu; Changchun Tu; Chaoan Xin; Hua Xuan; Qingwen Meng; Yonggang Liu; Yedong Yu; Yuntao Guan; Yu Jiang; Xunnan Yin; Gary Crameri; Muping Wang; Changwen Li; Shengwang Liu; Ming Liao; Li Feng; Hua Xiang; Jinfu Sun; Jinding Chen; Yanwei Sun; Shoulin Gu; Nihong Liu; Dexia Fu; Bryan T Eaton; Lin-Fa Wang; Xiangang Kong
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 5.  SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.

Authors:  Guo-ping Zhao
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

6.  Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses.

Authors:  Zhi-yong Yang; Heidi C Werner; Wing-pui Kong; Kwanyee Leung; Elisabetta Traggiai; Antonio Lanzavecchia; Gary J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-10       Impact factor: 11.205

7.  Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.

Authors:  Michael J Moore; Tatyana Dorfman; Wenhui Li; Swee Kee Wong; Yanhan Li; Jens H Kuhn; James Coderre; Natalya Vasilieva; Zhongchao Han; Thomas C Greenough; Michael Farzan; Hyeryun Choe
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys.

Authors:  Josephine McAuliffe; Leatrice Vogel; Anjeanette Roberts; Gary Fahle; Steven Fischer; Wun-Ju Shieh; Emily Butler; Sherif Zaki; Marisa St Claire; Brian Murphy; Kanta Subbarao
Journal:  Virology       Date:  2004-12-05       Impact factor: 3.616

9.  An interferon-gamma-related cytokine storm in SARS patients.

Authors:  Kao-Jean Huang; Ih-Jen Su; Michel Theron; Yi-Chun Wu; Shu-Kuan Lai; Ching-Chuan Liu; Huan-Yao Lei
Journal:  J Med Virol       Date:  2005-02       Impact factor: 2.327

10.  Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.

Authors:  Yuxian He; Qingyu Zhu; Shuwen Liu; Yusen Zhou; Baoan Yang; Jiaming Li; Shibo Jiang
Journal:  Virology       Date:  2005-03-30       Impact factor: 3.616

View more
  45 in total

1.  Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.

Authors:  Matthew Frieman; Boyd Yount; Sudhakar Agnihothram; Carly Page; Eric Donaldson; Anjeanette Roberts; Leatrice Vogel; Becky Woodruff; Diana Scorpio; Kanta Subbarao; Ralph S Baric
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.

Authors:  Meagan Bolles; Damon Deming; Kristin Long; Sudhakar Agnihothram; Alan Whitmore; Martin Ferris; William Funkhouser; Lisa Gralinski; Allison Totura; Mark Heise; Ralph S Baric
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 3.  Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation.

Authors:  Matthew Frieman; Ralph Baric
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

4.  Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells.

Authors:  Amy C Sims; Susan C Tilton; Vineet D Menachery; Lisa E Gralinski; Alexandra Schäfer; Melissa M Matzke; Bobbie-Jo M Webb-Robertson; Jean Chang; Maria L Luna; Casey E Long; Anil K Shukla; Armand R Bankhead; Susan E Burkett; Gregory Zornetzer; Chien-Te Kent Tseng; Thomas O Metz; Raymond Pickles; Shannon McWeeney; Richard D Smith; Michael G Katze; Katrina M Waters; Ralph S Baric
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

Review 5.  Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.

Authors:  John H Beigel; Hannah H Nam; Peter L Adams; Amy Krafft; William L Ince; Samer S El-Kamary; Amy C Sims
Journal:  Antiviral Res       Date:  2019-04-08       Impact factor: 5.970

6.  Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.

Authors:  Trevor Scobey; Boyd L Yount; Amy C Sims; Eric F Donaldson; Sudhakar S Agnihothram; Vineet D Menachery; Rachel L Graham; Jesica Swanstrom; Peter F Bove; Jeeho D Kim; Sonia Grego; Scott H Randell; Ralph S Baric
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

7.  Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus.

Authors:  Barry Rockx; Eric Donaldson; Matthew Frieman; Timothy Sheahan; Davide Corti; Antonio Lanzavecchia; Ralph S Baric
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

Review 8.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

9.  A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.

Authors:  Craig W Day; Ralph Baric; Sui Xiong Cai; Matt Frieman; Yohichi Kumaki; John D Morrey; Donald F Smee; Dale L Barnard
Journal:  Virology       Date:  2009-10-22       Impact factor: 3.616

Review 10.  SARS coronavirus accessory proteins.

Authors:  Krishna Narayanan; Cheng Huang; Shinji Makino
Journal:  Virus Res       Date:  2007-11-28       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.